Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Obalon Therapeutics Inc    OBLN

OBALON THERAPEUTICS INC (OBLN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/08/2018 10/09/2018 10/10/2018 10/11/2018 10/12/2018 Date
2.11(c) 2.34(c) 2.27(c) 2.36(c) 2.37(c) Last
71 938 35 325 31 703 14 800 7 752 Volume
-15.26% +10.90% -2.99% +3.96% +0.42% Change
More quotes
Financials (USD)
Sales 2018 9,57 M
EBIT 2018 -39,4 M
Net income 2018 -39,8 M
Debt 2018 -
Yield 2018 -
Sales 2019 14,9 M
EBIT 2019 -32,8 M
Net income 2019 -33,4 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 5,77x
Capi. / Sales2019 3,70x
Capitalization 55,2 M
More Financials
Company
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then... 
More about the company
Surperformance© ratings of Obalon Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on OBALON THERAPEUTICS INC
10/10OBALON THERAPEUTICS : Daina Schmidt Joins Obalon Therapeutics As Vice President,..
AQ
10/09Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing
GL
09/27OBALON THERAPEUTICS : FDA Grants PMA-S Approval for Obalon Touch Inflation Syste..
AQ
09/26OBALON THERAPEUTICS INC : Other Events, Financial Statements and Exhibits (form ..
AQ
09/26FDA Grants PMA-S Approval for Obalon Touch™ Inflation System
GL
08/30OBALON THERAPEUTICS : to Host Corporate Strategy Update Call with Investors and ..
AQ
08/29Obalon to Host Corporate Strategy Update Call with Investors and Analysts on ..
GL
08/28OBALON THERAPEUTICS : Announces Closing of $10 Million Private Placement
AQ
08/27OBALON THERAPEUTICS INC : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/27Obalon Therapeutics Announces Closing of $10 Million Private Placement
GL
More news
Sector news : Medical Devices & Implants
11:41aConvaTec shares plunge on profit warning and CEO departure
RE
10/10MEDTRONIC : Gets Regulatory Approval for Insulin Pump
DJ
10/05ESSILORLUXOTTICA : Italy' antitrust opens probe over Luxottica's acquisition of ..
RE
10/04Smiths Group to buy aircraft engine parts maker United Flexible in $345 milli..
RE
10/03ABBOTT LABORATORIES : Companies Lure New Workers With College Coaching, Student ..
DJ
More sector news : Medical Devices & Implants
Latest Tweets
10/10Obalon Therapeutics $OBLN Raised to Buy at Zacks Investment Research
1
10/09Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing
1
09/26Small-Cap Snapshot: Obalon Therapeutics pops after FDA approves gastric ballo.. 
09/26Analysts Set Obalon Therapeutics Inc $OBLN Target Price at $6.92  
09/26Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/26/2018)  
More tweets
Qtime:18
News from SeekingAlpha
09/26HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (09/26/2018) 
09/26Obalon up 15% on FDA nod for automated gastric balloon inflator 
09/18Midday Gainers / Losers (09/18/2018) 
09/14HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (09/14/2018) 
09/10Midday Gainers / Losers (09/10/2018) 
Chart OBALON THERAPEUTICS INC
Duration : Period :
Obalon Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OBALON THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 3,63 $
Spread / Average Target 53%
EPS Revisions
Managers
NameTitle
Andrew P. Rasdal Chief Executive Officer & Director
Kelly Huang President & Chief Operating Officer
Kim P. Kamdar Chairman
William John Plovanic Chief Financial Officer & Secretary
Mark Brister Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
OBALON THERAPEUTICS INC-64.15%55
STRYKER CORPORATION10.46%63 100
SMITH & NEPHEW0.58%14 991
WRIGHT MEDICAL GROUP NV20.79%3 342
GLAUKOS CORP129.47%1 995
JAPAN LIFELINE CO., LTD.-8.41%1 746